Quantcast

Latest Multiple myeloma Stories

2013-10-01 23:03:17

In-demand research report “Treating Refractory Hematological Malignancies - Multiple Myeloma (MM): New Treatment Options Driving In-Licensing and M&A” drawn up by MP Advisors has been recently published by Market Publishers Ltd. London,UK (PRWEB) October 01, 2013 Targeting unmet needs in treating hematological malignances through the development of innovative drugs has witnessed considerable achievements recently. Over the past 10 years, proteasome inhibitor Velcade (Bortezomib)...

2013-09-22 23:01:05

Treating Refractory Hematological Malignancies – Multiple Myeloma (MM): New Treatment Options Driving In-Licensing and M&A is the new research report added to ReportsnReports.com store. Dallas, TX (PRWEB) September 22, 2013 The report provides an overview of the therapies for Multiple Myeloma (Newly diagnosed - NDMM and relapsed/ refractory - RRMM), unmet need, and limitations of the current standard of care (SoC) for relapsed and refractory MM pts. The report highlights the...

2013-09-18 15:26:41

Findings provide insights for new, targeted cancer therapies in clinical trials Researchers have discovered why multiple myeloma, a difficult to cure cancer of the bone marrow, frequently recurs after an initially effective treatment that can keep the disease at bay for up to several years. Working in collaboration with colleagues at Princess Margaret Hospital in Toronto, researchers from Mayo Clinic in Arizona and the Translational Genomics Research Institute (TGen) in Phoenix were...

2013-08-19 13:11:48

A gene that helps control the aging process by acting as a cell's internal clock has been linked to cancer by a major new study. Scientists at The Institute of Cancer Research, London, found a genetic variant that influences the aging process among four new variants they linked to myeloma – one of the most common types of blood cancer. The study more than doubles the number of genetic variants linked to myeloma, bringing the total number to seven, and sheds important new light on the...

2013-07-22 23:24:22

The update will result in improved patient prognoses, better informed patient care decisions and reduced costs. (PRWEB) July 22, 2013 Signal Genetics today announced that it has launched an update to its MyPRS gene expression assay for patients with Multiple Myeloma, which will improve patient prognoses, enable better informed patient care decisions, and ultimately reduce costs. Every MyPRS test performed now includes an analysis of an additional set of 813-genes within the patient’s...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related